40 likes | 165 Views
MAY 24, 2019 AGM. LIST OF CANDIDATES AS DIRECTORS. Daniel Tassé. Chief Executive Officer and Director Born on 02/14/1960 in Montreal , QC, Canada Business address : DBV Technologies, 177/181 avenue Pierre Brossolette , 92120 Montrouge (France)
E N D
MAY 24, 2019 AGM LIST OF CANDIDATES AS DIRECTORS
Daniel Tassé Chief Executive Officer and Director Born on 02/14/1960 in Montreal, QC, Canada Business address : DBV Technologies, 177/181 avenue Pierre Brossolette, 92120 Montrouge (France) Other mandates and positions exercised in the last five years (excluding DBV Technologies) Director and Member of the Audit Committee and the Compensation Committee of Indivior PLC Director and Member of the Compensation Committee of Regenxbio Inc. Director and Member of the Audit Committee of HLS Therapeuticsfrom 2018 to 2019 Director and Member of the Audit Committee and the Compensation Committee of BellerophonTherapeutics Inc. CEO of AlcrestaThérapeutics Inc. from 2016 to 2018 CEO of Ikaria Inc., acquired by Mallinckrodt Pharmaceuticals Inc. from 2008 to 2015 Director of PhRMAfrom 2011 to 2015, stakeholder of the Healthcare Leadership Council and the Health Section Governing Board, for which he also co-chaired the Bioethics Committee. Shareholding 350,000 stock-options, in progress of vesting, giving the right to purchase 350,000 shares
Julie O’Neill Director Born on 25/02/1966 at Fermanagh, Ireland Business address : DBV Technologies, 177/181 avenue Pierre Brossolette, 92120 Montrouge (France) Other mandates and positions exercised in the last five years (excluding DBV Technologies) Director of HOOKIPA Pharma Inc. Director of National Institute for Bioprocessing Research and Training (NIBRT) Director, American Chamber of Commerce, Ireland, from 2016 to 2018 Vice President Global Operations, Alexion Pharmaceuticals, Inc., from 2015 to 2018 Senior Vice President, Manufacturing & Supply Chain Operations, Alexion Pharmaceuticals Inc., from 2014 to 2015 Chairman National Standards Authority of Ireland, (NSAI) from 2013 to 2017, Member of the Advisory board, Crann Institute, Trinity College Dublin, from 2012 to 2016 Shareholding 9,000 « BSAX 2017 » giving the right to purchase 9,000 shares 7,000 « BSA 2018 » giving the right to purchase 7,000 shares
Viviane Monges Independent Director Born on 10/15/1963 in Dunkerque Business address : DBV Technologies, 177/181 avenue Pierre Brossolette 92120 Montrouge (France) Other mandates and positions exercised in the last five years (excluding DBV Technologies) VP Finance & Control at Nestlé Business Excellence, CFO, Executive Committee member and Director at Galderma (Nestlé Skin Health), Director of Novo Holdings A/S, Director of Union ChimiqueBelge S.A. (UCB), Director of Idorsia Pharmaceuticals Ltd., Director of Voluntis S.A, Member of the Strategic Committee of NeoMedLight. Shareholding N/A